Ann LaCasce, MD, MMSc, director of the Dana-Farber/Massachusetts General Brigham Fellowship in Hematology/Oncology, ...
Hosted on MSN7mon
Antibody-drug conjugate highly effective in preventing recurrence in early stage HER2+ breast cancer, trial findsDana-Farber Cancer Institute. A year of treatment with a medicine made of an antibody and chemotherapy drug has proven highly effective in preventing stage 1 HER2-positive breast cancer from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback